ANIK Q4 2025 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$213M

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$31M+2473.3% YoY

Gross Profit

$19M62.6% margin

Operating Income

$646,0002.1% margin

Net Income

$292,0001.0% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

+10.1%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$190M

Total Liabilities

$47M

Stockholders' Equity

$143M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	-$1M	+2473.3%
Gross Profit	$19M	$23M	-15.0%
Operating Income	$646,000	$28M	-97.7%
Net Income	$292,000	-$22M	+101.3%

Geographic Segments

UNITED STATES

$18M75%

Europe

$6M25%